Search NASA⌕ Search

SEARCH · Search NASA

Results for “Main”

Search indexed NASA NTRS and DOE OSTI research on propulsion, heat transfer, battery materials and energy systems. Follow report and document links to the original sources.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 523 records · Page 29

Secondary Electron Yield Measurements of Fermilab?s Main Injector Vacuum Vessel

We discuss the progress made on a new installation in Fermilab's Main Injector that will help investigate the electron cloud phenomenon by making direct measurements of the secondary electron yield (SEY) of samples irradiated in the accelerator. In the Project X upgrade the Main Injector will have its beam intensity increased by a factor of three compared to current operations. This may result in the beam being subject to instabilities from the electron cloud. Measured SEY values can be used to further constrain simulations and aid our extrapolation to Project X intensities. The SEY test-stand, developed in conjunction with Cornell and SLAC, is capable of measuring the SEY from samples using an incident electron beam when the samples are biased at different voltages. We present the design and manufacture of the test-stand and the results of initial laboratory tests on samples prior to installation.

43 PARTICLE ACCELERATORS↗

Installation Status of the Electron Beam Profiler for the Fermilab Main Injector

The planned neutrino program at Fermilab requires large proton beam intensities in excess of 2 MW. Measuring the transverse profiles of these high intensity beams is challenging and often depends on non-invasive techniques. One such technique involves measuring the deflection of a probe beam of electrons with a trajectory perpendicular to the proton beam. A device such as this is already in use at the Spallation Neutron Source at ORNL and the installation of a similar device is underway in the Main Injector at Fermilab. The present installation status of the electron beam profiler for the Main Injector will be discussed together with some simulations and test stand results.

43 PARTICLE ACCELERATORS↗

Electron Cloud Measurements in Fermilab Main Injector and Recycler

This conference paper presents a series of electron cloud measurements in the Fermilab Main Injector and Recycler. A new instability was observed in the Recycler in July 2014 that generates a fast transverse excitation in the first high intensity batch to be injected. Microwave measurements of electron cloud in the Recycler show a corresponding depen- dence on the batch injection pattern. These electron cloud measurements are compared to those made with a retard- ing field analyzer (RFA) installed in a field-free region of the Recycler in November. RFAs are also used in the Main Injector to evaluate the performance of beampipe coatings for the mitigation of electron cloud. Contamination from an unexpected vacuum leak revealed a potential vulnerability in the amorphous carbon beampipe coating. The diamond-like carbon coating, in contrast, reduced the electron cloud signal to 1% of that measured in uncoated stainless steel beampipe.

Eldred, Jeffrey Scott↗

Spin Tracking of Polarized Protons in the Main Injector at Fermilab

The Main Injector (MI) at Fermilab currently produces high-intensity beams of protons at energies of 120 GeV for a variety of physics experiments. Acceleration of polarized protons in the MI would provide opportunities for a rich spin physics program at Fermilab. To achieve polarized proton beams in the Fermilab accelerator complex, shown in Fig.1.1, detailed spin tracking simulations with realistic parameters based on the existing facility are required. This report presents studies at the MI using a single 4-twist Si-berian snake to determine the depolarizing spin resonances for the relevant synchrotrons. Results will be presented first for a perfect MI lattice, followed by a lattice that includes the real MI imperfections, such as the measured magnet field errors and quadrupole misalignments. The tolerances of each of these factors in maintaining polariza-tion in the Main Injector will be discussed.

Xiao, M.↗

Electron Beam Profiler for the Fermilab Main Injector

The long range plan for Fermilab calls for large proton beam intensities in excess of 2 MW for use in the neutrino program. Measuring the transverse profiles of these high intensity beams is challenging and generally relies on non-invasive techniques. One such technique involves measuring the deflection of a beam of electrons with a trajectory perpendicular to the proton beam. A device such as this is already in use at the Spallation Neutron Source at ORNL and a similar device will be installed shortly in the Fermilab Main Injector. The Main Injector device is discussed in detail and some test results and simulations are shown

Thurman-Keup, R.↗

Investigating Main and High-Speed Shaft Bearing Reliability through Uptower Testing

The most prevalent failure modes in wind turbine drivetrains are main bearing failures stemming from micropitting, white etching or axial cracks in gearbox bearings, and generator bearing failures. These failures are neither well understood nor accounted for in design standards; consequently, the mitigation strategies being developed and fielded may only partially address the physics of failure and can take years to assess. The U.S. Department of Energy continues to support research programs to investigate the influence of rolling element sliding on the formation of bearing axial cracks and main bearing micropitting.

17 WIND ENERGY↗

Measurement of Electron Cloud Development in the Fermilab Main Injector Using Microwave Transmission

The production of an Electron Cloud poses stability issues for future high intensity running of the Fermilab Main Injector. Recent experiements have shown the presense of the electron cloud can be detected by the phase shift of a TE wave propagated along the beampipe. This technique has been employed to provide very sensitive measurements of the electron cloud development in the Fermilab Main Injector.

43 PARTICLE ACCELERATORS↗

Synchronous High-frequency Distributed Readout For Edge Processing At The Fermilab Main Injector And Recycler

The Main Injector (MI) was commissioned using data acquisition systems developed for the Fermilab Main Ring in the 1980s. New VME-based instrumentation was commissioned in 2006 for beam loss monitors (BLM)[2], which provided a more systematic study of the machine and improved displays of routine operation. However, current projects are demanding more data and at a faster rate from this aging hardware. One such project, Real-time Edge AI for Distributed Systems (READS), requires the high-frequency, low-latency collection of synchronized BLM readings from around the approximately two-mile accelerator complex. Significant work has been done to develop new hardware to monitor the VME backplane and broadcast BLM measurements over Ethernet, while not disrupting the existing operations critical functions of the BLM system. This paper will detail the design, implementation, and testing of this parallel data pathway.

43 PARTICLE ACCELERATORS↗

The QWeak Experiment's Main Detector System

The QWeak experiment will determine the weak charge of the proton Qpw to 4\% accuracy by measuring the parity violating electron scattering asymmetry from a liquid Hydrogen target at a fixed Q2. The Standard Model makes a precise prediction of the value of Qpw, and as such makes it sensitive to new physics. QWeak's main detector subsystem is comprised of eight identical 2 m long quartz bar \^{C}erenkov detectors that can operate in both integrating and counting configurations, depending on the task at hand. Where integrated detector yields are required to measure asymmetries, counting mode data acquisition is required in order to properly characterize detector performance as well as accurately measure momentum Q2. A summary and status review of the main detectors will be discussed for each running mode.

MacEwan, Scott↗

Study on main control room and human-system interface of generation III in China - 313

This paper focuses on the study on Main Control Room (MCR) and Human-System Interface (HSI) of Generation III in China. An intelligent HSI has been developed to enhance the safety and availability of Nuclear Power Plant (NPP) by improving operational reliability. The key elements of the proposed HSI such as Advanced Alarm System, State Oriented Procedures (SOP), Large Display Panel (LDP), Computerized-base procedures..., that affects what information the operator sees or the system's response to a control input must be empirically evaluated to ensure that the new design does not compromise HSI effectiveness. Based on CPR1000's experience in China, this paper presents the approach used as well as the most relevant aspects of this kind of project for the next generation. This approach will be used in new Generation III nuclear power plant, and also used in modernizing I and C system in currently operative nuclear power plants, in addition to meeting safety requirements and the plant's operational requirements, to improve cost-effective plant and human performance and to reduce likelihood of human errors, to gain maximum benefit of the implemented technology and to increase the performance, resulting in improved plant safety, availability, reliability, and cost-effective operation. The proposed HSI has been validated and demonstrated using the CPR1000 simulator of National Key Laboratory. After sufficient validation, the characteristic design features of the proposed HSI will be reflected in the design of the main control room of the next generation reactors in China. (authors)

21 SPECIFIC NUCLEAR REACTORS AND ASSOCIATED PLANTS↗

Fermilab Main Injector Collimation Systems: Design, Commissioning and Operation

The Fermilab Main Injector is moving toward providing 400 kW of 120 GeV proton beams using slip stacking injection of eleven Booster batches. Loss of 5% of the beam at or near injection energy results in 1.5 kW of beam loss. A collimation system has been implemented to localize this loss with the design emphasis on beam not captured in the accelerating RF buckets. More than 95% of these losses are captured in the collimation region. We will report on the construction, commissioning and operation of this collimation system. Commissioning studies and loss measurement tools will be discussed. Residual radiation monitoring of the Main Injector machine components will be used to demonstrate the effectiveness of these efforts.

43 PARTICLE ACCELERATORS↗

Accurate simulation of the electron cloud in the Fermilab Main Injector with VORPAL

Precision simulations of the electron cloud at the Fermilab Main Injector have been studied using the plasma simulation code VORPAL. Fully 3D and self consistent solutions that includes E.M. field maps generated by the cloud and the proton bunches have been obtained, as well detailed distributions of the electron's 6D phase space. We plan to include such maps in the ongoing simulation of the space charge effects in the Main Injector. Simulations of the response of beam position monitors, retarding field analyzers and microwave transmission experiments are ongoing.

43 PARTICLE ACCELERATORS↗

Contribution of the catalytic dyad of SARS-CoV-2 main protease to binding covalent and noncovalent inhibitors

The effect of mutations of the catalytic dyad residues of SARS-CoV-2 main protease (MPro WT ) on the thermodynamics of binding of covalent inhibitors comprising nitrile [nirmatrelvir (NMV), NBH2], aldehyde (GC373), and ketone (BBH1) warheads to MPro is examined together with room temperature X-ray crystallography. When lacking the nucleophilic C145, NMV binding is ~400-fold weaker corresponding to 3.5 kcal/mol and 13.3 °C decrease in free energy (ΔG) and thermal stability (T m ), respectively, relative to MPro WT . The H41A mutation results in a 20-fold increase in the dissociation constant (K d ), and 1.7 kcal/mol and 1.4 °C decreases in ΔG and T m , respectively. Increasing the pH from 7.2 to 8.2 enhances NMV binding to MPro H41A , whereas no significant change is observed in binding to MPro WT . Structures of the four inhibitor complexes with MPro 1-304/C145A show that the active site geometries of the complexes are nearly identical to that of MPro WT with the nucleophilic sulfur of C145 positioned to react with the nitrile or the carbonyl carbon. These results support a two-step mechanism for the formation of the covalent complex involving an initial non-covalent binding followed by a nucleophilic attack by the thiolate anion of C145 on the warhead carbon. Noncovalent inhibitor ensitrelvir (ESV) exhibits a binding affinity to MPro WT that is similar to NMV but differs in its thermodynamic signature from NMV. The binding of ESV to MPro C145A also results in a significant, but smaller, increase in K d and decrease in ΔG and T m , relative to NMV.

37 INORGANIC, ORGANIC, PHYSICAL, AND ANALYTICAL CH↗

Unmasking the Conformational Stability and Inhibitor Binding to SARS-CoV-2 Main Protease Active Site Mutants and Miniprecursor

We recently demonstrated that inhibitor binding reorganizes the oxyanion loop of a monomeric catalytic domain of SARS CoV-2 main protease (MPro) from an unwound (E) to a wound (active, E*) conformation, independent of dimerization. Here we assess the effect of the flanking N-terminal residues, to imitate the MPro precursor prior to its autoprocessing, on conformational equilibria rendering stability and inhibitor binding. Thermal denaturation (T m ) of C145A mutant, unlike H41A, increases by 6.8 °C, relative to wild-type mature dimer. An inactivating H41A mutation to maintain a miniprecursor containing TSAVL[Q or E] of the flanking nsp4 sequence in an intact form [ (-6) MPro H41A and (-6*) MPro H41A , respectively], and its corresponding mature MPro H41A were systematically examined. While the H41A mutation exerts negligible effect on T m and dimer dissociation constant (K dimer ) of MPro H41A , relative to the wild type MPro, both miniprecursors show a 4–5 °C decrease in T m and > 85-fold increase in K dimer as compared to MPro H41A . The K d for the binding of the covalent inhibitor GC373 to (-6*) MPro H41A increases ~12-fold, relative to MPro H41A , concomitant with its dimerization. While the inhibitor-free dimer exhibits a state in transit from E to E* with a conformational asymmetry of the protomers’ oxyanion loops and helical domains, inhibitor binding restores the asymmetry to mature-like oxyanion loop conformations (E*) but not of the helical domains. Finally, disorder of the terminal residues 1–2 and 302–306 observed in both structures suggest that N-terminal autoprocessing is tightly coupled to the E-E* equilibrium and stable dimer formation.

59 BASIC BIOLOGICAL SCIENCES↗

Unusual zwitterionic catalytic site of SARS–CoV-2 main protease revealed by neutron crystallography

The main protease (3CL M pro ) from SARS–CoV-2, the etiological agent of COVID-19, is an essential enzyme for viral replication. 3CL M pro possesses an unusual catalytic dyad composed of Cys 145 and His 41 residues. A critical question in the field has been what the protonation states of the ionizable residues in the substrate-binding active-site cavity are; resolving this point would help understand the catalytic details of the enzyme and inform rational drug development against this pernicious virus. Here, we present the room-temperature neutron structure of 3CL M pro , which allowed direct determination of hydrogen atom positions and, hence, protonation states in the protease. We observe that the catalytic site natively adopts a zwitterionic reactive form in which Cys 145 is in the negatively charged thiolate state and His 41 is doubly protonated and positively charged, instead of the neutral unreactive state usually envisaged. The neutron structure also identified the protonation states, and thus electrical charges, of all other amino acid residues and revealed intricate hydrogen-bonding networks in the active-site cavity and at the dimer interface. The fine atomic details present in this structure were made possible by the unique scattering properties of the neutron, which is an ideal probe for locating hydrogen positions and experimentally determining protonation states at near-physiological temperature. Our observations provide critical information for structure-assisted and computational drug design, allowing precise tailoring of inhibitors to the enzyme's electrostatic environment.

37 INORGANIC, ORGANIC, PHYSICAL, AND ANALYTICAL CH↗

On dysprosium utilisation in multi-main-phase Nd–Dy–Fe–B magnets with core–shell microstructures

The development of high-performance Nd–Dy–Fe–B magnets that minimise the consumption of the scarce rare earth (RE) element Dy remains a major global scientific and technological quest. Here, we designed an alloy microstructure comprising of a uniform Dy-lean core–Dy-rich shell in a series of multi-main-phase (MMP) Nd–Dy–Fe–B magnets. The resulting MMP Dy1 and Dy3 magnets with an overall Dy level of 1 and 3 wt.% possessed values of 0.48 and 0.29 T/wt.% of coercivity increment per unit weight percentage of the Dy addition, respectively. Most importantly, the resulting MMP Dy3 magnet exhibited a high coercivity (2.38 T), an excellent thermal stability of the coercivity (|β| = 0.531%/°C), a high squareness factor (> 95%), all with little diminishment in the remanent magnetisation (1.35 T) and maximum energy product (43.6 MGOe). These properties are superior to the currently available sintered Nd–Dy–Fe–B magnets which utilise higher levels of Dy of 5 wt.%. Via magnetic and multi-scale microstructural characterisation experiments and micromagnetic simulations, the formation of the Dy-lean core–Dy-rich shell microstructure is rationalised via solid-state-diffusion and solution reprecipitation during liquid-phase sintering. The Dy-lean core–Dy-rich shell microstructure and the non-ferromagnetic low-Fe RE-rich grain boundary phase led to the synergistic magnetic performance. This is significant in the context of the MMP Nd–Dy–Fe–B magnets being applied to large-scale production. The present work establishes a pathway for the more sustainable utilisation of Dy in permanent magnets via formation of a uniform core–shell microstructure.

36 MATERIALS SCIENCE↗

A multi-pronged evaluation of aldehyde-based tripeptidyl main protease inhibitors as SARS-CoV-2 antivirals

As an essential enzyme of SARS-CoV-2, the COVID-19 pathogen, main protease (M Pro ) is a viable target to develop antivirals for the treatment of COVID-19. By varying chemical compositions at both P2 and P3 positions and the N-terminal protection group, we synthesized 18 tripeptidyl M Pro inhibitors that contained also an aldehyde warhead and β-(S-2-oxopyrrolidin-3-yl)-alaninal at the P1 position. Systematic characterizations of these inhibitors were conducted, including their in vitro enzymatic inhibition potency, X-ray crystal structures of their complexes with M Pro , their inhibition of M Pro transiently expressed in 293T cells, and cellular toxicity and SARS-CoV-2 antiviral potency of selected inhibitors. These inhibitors have a large variation of determined in vitro enzymatic inhibition IC 50 values that range from 4.8 to 650 nM. Here, the determined in vitro enzymatic inhibition IC 50 values reveal that relatively small side chains at both P2 and P3 positions are favorable for achieving high in vitro M Pro inhibition potency, the P3 position is tolerable toward unnatural amino acids with two alkyl substituents on the α-carbon, and the inhibition potency is sensitive toward the N-terminal protection group. X-ray crystal structures of M Pro bound with 16 inhibitors were determined. In all structures, the M Pro active site cysteine interacts covalently with the aldehyde warhead of the bound inhibitor to form a hemithioacetal that takes an S configuration. For all inhibitors, election density around the N-terminal protection group is weak indicating possible flexible binding of this group to M Pro . In M Pro , large structural variations were observed on residues N142 and Q189. Unlike their high in vitro enzymatic inhibition potency, most inhibitors showed low potency to inhibit M Pro that was transiently expressed in 293T cells. Inhibitors that showed high potency to inhibit M Pro transiently expressed in 293T cells all contain O-tert-butyl-threonine at the P3 position. These inhibitors also exhibited relatively low cytotoxicity and high antiviral potency. Overall, our current and previous studies indicate that O-tert-butyl-threonine at the P3 site is a key component to achieve high cellular and antiviral potency for tripeptidyl aldehyde inhibitors of M Pro .

60 APPLIED LIFE SCIENCES↗

A systematic exploration of boceprevir-based main protease inhibitors as SARS-CoV-2 antivirals

Boceprevir is an HCV NSP3 inhibitor that was explored as a repurposed drug for COVID-19. It inhibits the SARS-CoV-2 main protease (M Pro ) and contains an α-ketoamide warhead, a P1 β-cyclobutylalanyl moiety, a P2 dimethylcyclopropylproline, a P3 tert-butylglycine, and a P4 N-terminal tert-butylcarbamide. By introducing modifications at all four positions, we synthesized 20 boceprevir-based M Pro inhibitors including PF-07321332 and characterized their M Pro inhibition potency in test tubes (in vitro) and 293T cells (in cellulo). Crystal structures of M Pro bound with 10 inhibitors and cytotoxicity and antiviral potency of 4 inhibitors were characterized as well. Replacing the P1 site with a β-(S-2-oxopyrrolidin-3-yl)-alanyl (Opal) residue and the warhead with an aldehyde leads to high in vitro potency. The original moieties at P2, P3 and the P4 N-terminal cap positions in boceprevir are better than other tested chemical moieties for high in vitro potency. In crystal structures, all inhibitors form a covalent adduct with the M Pro active site cysteine. Here, the P1 Opal residue, P2 dimethylcyclopropylproline and P4 N-terminal tert-butylcarbamide make strong hydrophobic interactions with M Pro , explaining high in vitro potency of inhibitors that contain these moieties. A unique observation was made with an inhibitor that contains a P4 N-terminal isovaleramide. In its M Pro complex structure, the P4 N-terminal isovaleramide is tucked deep in a small pocket of M Pro that originally recognizes a P4 alanine side chain in a substrate. Although all inhibitors show high in vitro potency, they have drastically different in cellulo potency to inhibit ectopically expressed M Pro in human 293T cells. In general, inhibitors with a P4 N-terminal carbamide or amide have low in cellulo potency. This trend is reversed when the P4 N-terminal cap is changed to a carbamate. The installation of a P3 O-tert-butyl-threonine improves in cellulo potency. Three molecules that contain a P4 N-terminal carbamate were advanced to cytotoxicity tests on 293T cells and antiviral potency tests on three SARS-CoV-2 variants. They all have relatively low cytotoxicity and high antiviral potency with EC 50 values around 1 μM. A control compound with a nitrile warhead and a P4 N-terminal amide has undetectable antiviral potency. Based on all observations, we conclude that a P4 N-terminal carbamate in a boceprevir derivative is key for high antiviral potency against SARS-CoV-2.

60 APPLIED LIFE SCIENCES↗